Please login to the form below

Not currently logged in

Pharmaceutical Market Europe - March 2012

PME March 2012This issue PME talks to …

… Stephan Tanda

Chairman of EuropaBio explains how he believes that accelerating uptake of biotechnologies can address European and world challenges 

And we take a look at …

Translational medicine

Roger Palframan, global project leader at UCB Pharma explores why collaborating in networks with academia can pay dividends for pharma

Regulation: keeping abreast of legislative changes

Sandra Rafferty and Nick Beckett of CMS Cameron McKenna urge companies to be vigilant in keeping up to date with the plethora of new legislation coming through for medicines and devices nationally and internationally

Market access: has HTA hijacked the innovation debate?

Society’s views should be taken into account at the earliest opportunity so that price is not the only consideration when recommending a drug

… Germany: hanging in the balance

With a tradition of invention in the medical field that brought us aspirin, Germany has been an attractive pharma market for years – will the threat of a worsening economic crisis change that?

View: March 2012 PME online 

Register here to receive email notification of future digital editions of PME or contact the subscriptions department to enquire about receiving a print copy of the magazine. More PMLiVE digital editions can be found here.

PME is also available to download as an app for iPhone and iPad

Please note: Some older digital editions may no longer be accessible while we transition to a new digital edition system and app -

COVID-19 Updates and Daily News

Featured jobs


Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...